Sight Sciences Stock Quote SGHT - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

5.28

Bid

3.89

Ask

6.10

Volume

0.00 Day's Range 0.00

1.04 52 Week Range 11.20

Market Cap

261.146M

Previous Close

5.28

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

162,758

Shares Outstanding

49,553,371

Dividend Yield

PE Ratio

-4.70

Earnings Per Share (EPS)

-1.12

Revenue

81.06M

Net Profit

-55.55M

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilit... Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.sightsciences.com

Headquarters

Dover, Delaware, USA

Founded

1970

Sight Sciences Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker SGHT. The last closing price for Sight Sciences was $5.28. Over the last year, Sight Sciences shares have traded in a share price range of $ 1.04 to $ 11.20.

Sight Sciences currently has 49,553,371 shares outstanding. The market capitalization of Sight Sciences is $261.15 million. Sight Sciences has a price to earnings ratio (PE ratio) of -4.70.

Sight Sciences to Report First Quarter Financial Results on May 2, 2024

MENLO PARK, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and...

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2

MENLO PARK, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and...

Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Clinical results demonstrate long-term efficacy of the OMNI® Surgical System for primary open-angle glaucoma and support use of TearCare® technology as a primary treatment for dry eye disease...

Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference

MENLO PARK, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and...

Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance

MENLO PARK, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and...

Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024

MENLO PARK, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.14	2.72373540856	5.14	5.88	5.01	161729	5.36891411	CS
4	-0.02	-0.377358490566	5.3	6.3425	4.88	215501	5.48668993	CS
12	1.08	25.7142857143	4.2	6.3425	4.01	162758	4.93465702	CS
26	3.8	256.756756757	1.48	6.3425	1.13	384359	4.30648411	CS
52	-4.43	-45.623069001	9.71	11.2	1.04	312928	4.41638384	CS
156	-24.72	-82.4	30	42.57	1.04	269015	11.40198098	CS
260	-24.72	-82.4	30	42.57	1.04	269015	11.40198098	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.33 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 61.48 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.75 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.53 (0.00%)	0
AACGATA Creativity Global	$ 0.87 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.33 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 61.48 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.75 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.53 (0.00%)	0
AACGATA Creativity Global	$ 0.87 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.33 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 61.48 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.75 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.53 (0.00%)	0
AACGATA Creativity Global	$ 0.87 (0.00%)	0